Structural Biology and Cancer: Using Structural Biology to Develop Immunotherapies
This talk will focus on early-stage work in the Starbird lab to investigate the structural basis for how receptor tyrosine kinases (RTKs) are activated in the context of cancer or diseased states as opposed to in normal signaling, as well as how we can utilize that information in therapeutic design. Current work is focused on…